These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30066228)
1. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Zampino R; Marrone A; Rinaldi L; Guerrera B; Nevola R; Boemio A; Iuliano N; Giordano M; Passariello N; Sasso FC; Albano E; Adinolfi LE Infection; 2018 Dec; 46(6):793-799. PubMed ID: 30066228 [TBL] [Abstract][Full Text] [Related]
2. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983 [TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516 [TBL] [Abstract][Full Text] [Related]
5. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
6. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985 [TBL] [Abstract][Full Text] [Related]
7. Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC). Fierbinţeanu-Braticevici C; Mohora M; Creţoiu D; Creţoiu S; Petrişor A; Usvat R; Ion DA Rom J Morphol Embryol; 2009; 50(3):407-12. PubMed ID: 19690766 [TBL] [Abstract][Full Text] [Related]
8. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C. Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296 [TBL] [Abstract][Full Text] [Related]
11. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C. El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. Mera K; Uto H; Mawatari S; Ido A; Yoshimine Y; Nosaki T; Oda K; Tabu K; Kumagai K; Tamai T; Moriuchi A; Oketani M; Shimada Y; Hidaka M; Eguchi S; Tsubouchi H BMC Gastroenterol; 2014 Feb; 14():27. PubMed ID: 24524410 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. Patel K; Thompson AJ; Chuang WL; Lee CM; Peng CY; Shanmuganathan G; Thongsawat S; Tanwandee T; Mahachai V; Pramoolsinsap C; Cho M; Han KH; Shah SR; Foster GR; Clark PJ; Pulkstenis E; Subramanian GM; McHutchison JG J Gastroenterol Hepatol; 2011 Jul; 26(7):1182-8. PubMed ID: 21410752 [TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957 [TBL] [Abstract][Full Text] [Related]
16. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients. Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832 [TBL] [Abstract][Full Text] [Related]
17. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hashemi SM; van der Poorten D; Barrera F; Bandara P; Lux O; Kench J; George J Hepatol Int; 2013 Jun; 7(2):516-23. PubMed ID: 26201783 [TBL] [Abstract][Full Text] [Related]
19. Iron and proinflammatory cytokines in chronic hepatitis C virus infection. López-Prieto J; González-Reimers E; Alemán-Valls MR; de la Vega-Prieto MJ; Abreu-González P; Pelazas-González R; Hernández-Luis R; Jorge-Ripper C; Santolaria-Fernández F Biol Trace Elem Res; 2013 Oct; 155(1):5-10. PubMed ID: 23892696 [TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy. Khattab MA; Abdel-fattah ME; Eslam M; Abdelaleem A; Abdelaleem RA; Shatat M; Ali A; Hamdy L; Tawfek H J Clin Gastroenterol; 2010; 44(10):707-12. PubMed ID: 20195166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]